A United Kingdom supplier, with 9 awarded contracts, totalling £190.1m, most recently 3 months ago.
This contract involves the supply of medications from therapeutic programs for a duration of 24 months, covering 198 tasks. The total value of the contract is approximately €54,007,190.91. The buyer is the University Clinical Hospital of Jan Mikulicz-Radecki in Wrocław, Poland. Suppliers are invited
This contract involves the delivery of medications for treatment programs, chemotherapy, and RDTL (Drug Therapy for Patients) to ensure the therapy of patients treated at the Independent Public Clinical Hospital named after A. Mielęcki of the Silesian Medical University in Katowice. The total value
This contract involves the supply of pharmaceutical products, divided into four distinct parts. The buyer is the University Clinical Center named after Professor K. Gibiński of the Silesian Medical University in Katowice, Poland. The total value of the contract is approximately 5,323,890.40 EUR. Sup
This contract involves the supply of medicinal products as specified in the attached document (Annex 3 to the SWZ). The estimated quantities and requirements for the products are detailed in this annex. Suppliers are invited to provide these pharmaceutical products to the University Clinical Center.
This contract involves the supply of 900 packages of the medication Kaftrio, which is part of a pharmaceutical program. The supplied medication must comply with the Pharmaceutical Law of September 6, 2001. This purchase is part of the B.112 pharmaceutical program, which is funded by the National Hea
This contract involves the supply of medicinal products for a duration of 24 months. The total value of the contract is approximately €781,044.66. The buyer is the University Clinical Hospital of Jan Mikulicz-Radecki in Wrocław, Poland. Suppliers are invited to provide pharmaceutical products that m
This contract involves the procurement and ongoing delivery of pharmaceutical products for drug programs and chemotherapy. The total value of the contract is approximately €47,077,429.62. The buyer is the National Medical Institute of the Ministry of Internal Affairs and Administration in Poland. Su
This contract involves the supply of the medication Burosumab as part of a treatment program for patients with X-Linked Hypophosphatemia (XLH), classified under ICD-10 code E.83.3. The contracting authority does not allow partial bids, meaning the contract cannot be divided into smaller parts. Addit
This procurement opportunity involves the supply of specific medications for the treatment of cystic fibrosis. The required products include: 1. Ivacaftor 60 mg + Tezacaftor 40 mg + Elexacaftor 80 mg in 28 sachets - 20 packages 2. Ivacaftor 75 mg + Tezacaftor 50 mg + Elexacaftor 100 mg in 28 sachets
